Moderna to Supply Brazil 12.5 million COVID-19 Vaccines

  Moderna, Inc. (NASDAQ:MRNA) today announced a contract with the Ministry of Health in Brazil (Ministério da Saúde) to supply its mRNA COVID-19 vaccine as an integral part of Brazil's 2024 national vaccination campaign against COVID-19. This contract follows the Brazilian Health Regulatory Agency's (ANVISA) approval of Moderna's COVID-19 vaccine in March 2024, which encodes the spike protein of the XBB.1.5 sublineage of SARS-CoV-2 for active immunization for the prevention of COVID-19 in children from six months of age and adults.

https://www.accesswire.com/855291/moderna-announces-contract-with-brazil-to-supply-125-million-covid-19-vaccines-as-part-of-national-vaccination-campaign